- Home
- FITB vs STE Comparison
FITB vs STE Comparison
Compare FITB & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FITB
- STE
- Stock Information
- Founded
- FITB 1858
- STE 1985
- Country
- FITB United States
- STE United States
- Employees
- FITB N/A
- STE N/A
- Industry
- FITB Major Banks
- STE Industrial Specialties
- Sector
- FITB Finance
- STE Health Care
- Exchange
- FITB Nasdaq
- STE Nasdaq
- Market Cap
- FITB 25.6B
- STE 22.1B
- IPO Year
- FITB N/A
- STE 1992
- Fundamental
- Price
- FITB $34.15
- STE $222.23
- Analyst Decision
- FITB Buy
- STE Buy
- Analyst Count
- FITB 16
- STE 6
- Target Price
- FITB $48.44
- STE $260.00
- AVG Volume (30 Days)
- FITB 6.6M
- STE 630.5K
- Earning Date
- FITB 04-17-2025
- STE 05-07-2025
- Dividend Yield
- FITB 4.33%
- STE 1.04%
- EPS Growth
- FITB 2.37
- STE N/A
- EPS
- FITB 3.21
- STE 4.72
- Revenue
- FITB $7,907,000,000.00
- STE $5,398,371,000.00
- Revenue This Year
- FITB $15.95
- STE $7.09
- Revenue Next Year
- FITB $5.23
- STE $6.31
- P/E Ratio
- FITB $10.62
- STE $35.73
- Revenue Growth
- FITB N/A
- STE 15.29
- 52 Week Low
- FITB $32.25
- STE $197.82
- 52 Week High
- FITB $49.07
- STE $248.24
- Technical
- Relative Strength Index (RSI)
- FITB 36.40
- STE 50.92
- Support Level
- FITB $32.27
- STE $218.96
- Resistance Level
- FITB $35.57
- STE $225.03
- Average True Range (ATR)
- FITB 1.89
- STE 7.91
- MACD
- FITB -0.05
- STE 0.25
- Stochastic Oscillator
- FITB 25.40
- STE 71.88
About FITB Fifth Third Bancorp
Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati. The company has over $200 billion in assets and operates numerous full-service banking branches and ATMs throughout Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, and North Carolina.
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.